Trial Profile
Pharmacokinetics of cobicistat boosted-elvitegravir in combination with rifabutin in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Cobicistat (Primary) ; Elvitegravir (Primary) ; Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary) ; Rifabutin (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Gilead Sciences
- 17 Nov 2015 New trial record